are glp-1 receptor agonists banned by wada 2025 2026 Prohibited List Now in Effect: Why Olympic Athletes Need More Than "Checked Box" Certification GLP-1 Agonists Weight Loss Drugs
Description
J., Khutoryansky, N., Zdravkovic, M., Sprenger, C
Concerns about thyroid cancer risk and the potential for sarcopenia or bone fragility in older patients further underscore the need for long-term surveillance (Nunn et al., 2024)
That year 390 million children and adolescents aged 5-19 were thought to be overweight, of whom 160 million were obese (WHO 2024)
Comorbidities diabetes, heart disease, or fatty liver disease may influence drug choice
Billington CJ, Briggs JE, Link JG, et al
V., Gier, B., Elashoff, R
